Cottage Street Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.53M | Buy |
10,050
+611
| +6% | +$131K | 0.98% | 29 |
|
|
2026
Q1 | $2.05M | Sell |
9,439
-496
| -5% | -$110K | 0.89% | 32 |
|
|
2025
Q4 | $2.27M | Buy |
9,935
+260
| +3% | +$59.2K | 0.96% | 27 |
|
|
2025
Q3 | $2.24M | Buy |
9,675
+507
| +6% | +$103K | 0.95% | 28 |
|
|
2025
Q2 | $1.7M | Buy |
9,168
+4,693
| +105% | +$872K | 0.89% | 32 |
|
|
2025
Q1 | $938K | Buy |
4,475
+21
| +0.5% | +$4.08K | 0.47% | 45 |
|
|
2024
Q4 | $792K | Sell |
4,454
-187
| -4% | -$34.4K | 0.41% | 51 |
|
|
2024
Q3 | $917K | Buy |
4,641
+6
| +0.1% | +$1.12K | 0.5% | 44 |
|
|
2024
Q2 | $795K | Sell |
4,635
-75
| -2% | -$12.4K | 0.47% | 44 |
|
|
2024
Q1 | $858K | Sell |
4,710
-27
| -0.6% | -$4.65K | 0.52% | 46 |
|
|
2023
Q4 | $740K | Sell |
4,737
-23
| -0.5% | -$3.35K | 0.5% | 46 |
|
|
2023
Q3 | $709K | Buy |
4,760
+337
| +8% | +$49.5K | 0.52% | 48 |
|
|
2023
Q2 | $596K | Sell |
4,423
-64
| -1% | -$9.38K | 0.43% | 49 |
|
|
2023
Q1 | $715K | Buy |
+4,487
| New | +$686K | 0.55% | 46 |
|
|
2022
Q4 | – | Sell |
-4,484
| Closed | -$602K | – | 31 |
|
|
2022
Q3 | $602K | Buy |
4,484
+10
| +0.2% | +$1.44K | 0.49% | 50 |
|
|
2022
Q2 | $685K | Buy |
4,474
+19
| +0.4% | +$2.9K | 0.52% | 51 |
|
|
2022
Q1 | $722K | Buy |
4,455
+17
| +0.4% | +$2.47K | 0.43% | 52 |
|
|
2021
Q4 | $601K | Buy |
4,438
+226
| +5% | +$26.7K | 0.34% | 60 |
|
|
2021
Q3 | $454K | Buy |
4,212
+193
| +5% | +$22.1K | 0.31% | 62 |
|
|
2021
Q2 | $453K | Buy |
4,019
+172
| +4% | +$19.4K | 0.27% | 70 |
|
|
2021
Q1 | $416K | Buy |
3,847
+94
| +3% | +$10.1K | 0.27% | 71 |
|
|
2020
Q4 | $402K | Buy |
3,753
+195
| +5% | +$18.7K | 0.38% | 45 |
|
|
2020
Q3 | $312K | Buy |
3,558
+418
| +13% | +$39.4K | 0.23% | 77 |
|
|
2020
Q2 | $308K | Buy |
3,140
+40
| +1% | +$3.52K | 0.23% | 76 |
|
|
2020
Q1 | $236K | Hold |
3,100
| – | – | 0.21% | 81 |
|
|
2019
Q4 | $274K | Hold |
3,100
| – | – | 0.16% | 85 |
|
|
2019
Q3 | $235K | Hold |
3,100
| – | – | 0.14% | 91 |
|
|
2019
Q2 | $225K | Hold |
3,100
| – | – | 0.13% | 92 |
|
|
2019
Q1 | $250K | Hold |
3,100
| – | – | 0.15% | 84 |
|
|
2018
Q4 | $286K | Hold |
3,100
| – | – | 0.19% | 77 |
|
|
2018
Q3 | $293K | Hold |
3,100
| – | – | 0.17% | 76 |
|
|
2018
Q2 | $287K | Hold |
3,100
| – | – | 0.17% | 80 |
|
|
2018
Q1 | $293K | Hold |
3,100
| – | – | 0.18% | 75 |
|
|
2017
Q4 | $300K | Hold |
3,100
| – | – | 0.18% | 75 |
|
|
2017
Q3 | $275K | Hold |
3,100
| – | – | 0.17% | 73 |
|
|
2017
Q2 | $225K | Hold |
3,100
| – | – | 0.15% | 77 |
|
|
2017
Q1 | $202K | Buy |
+3,100
| New | +$195K | 0.14% | 79 |
|
Other funds holding ABBV
ECSS
ATO
Cottage Street Advisors's ABBV Position: Q2 2026 in Review
Cottage Street Advisors increased its AbbVie (ABBV) stake by 6.5% in Q2 2026, buying an estimated $131K and bringing the position to 10,050 shares worth $2.53M. The position accounts for 0.98% of the portfolio, ranked #29.
Cottage Street Advisors first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cottage Street Advisors held 10,050 shares of AbbVie worth $2.53M as of Q2 2026.
- Cottage Street Advisors bought 611 AbbVie shares in Q2 2026, an estimated $131K.
- AbbVie made up 0.98% of Cottage Street Advisors's portfolio in Q2 2026, its #29 holding.
- Cottage Street Advisors first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cottage Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.